Isovaleryl chloride → HCID 22181317, compound
Reaction equation
[CH:1]1([CH2:4][N:5]2[C:9]3[CH:10]=[CH:11][C:12]([NH:14][CH3:15])=[CH:13][C:8]=3[N:7]=[C:6]2[CH:16]([C:18]2[CH:23]=[CH:22][C:21]([O:24][CH2:25][CH3:26])=[CH:20][CH:19]=2)[CH3:17])[CH2:3][CH2:2]1.CCN(C(C)C)C(C)C.[C:36](Cl)(=[O:41])[CH2:37][CH:38]([CH3:40])[CH3:39]>CC#N.CN(C1C=CN=CC=1)C>[CH:1]1([CH2:4][N:5]2[C:9]3[CH:10]=[CH:11][C:12]([N:14]([CH3:15])[C:36](=[O:41])[CH2:37][CH:38]([CH3:40])[CH3:39])=[CH:13][C:8]=3[N:7]=[C:6]2[CH:16]([C:18]2[CH:19]=[CH:20][C:21]([O:24][CH2:25][CH3:26])=[CH:22][CH:23]=2)[CH3:17])[CH2:3][CH2:2]1Participants
Procedure
To a solution of 1-(cyclopropylmethyl)-2-[1-(4-ethoxyphenyl)ethyl]-N-methyl-1H-benzimidazol-5-amine (349.5 mg, 1.0 mmol) in MeCN (25 mL) was added DIPEA (258.5 mg, 2.0 mmol), DMAP (10 mg) and isovaleryl chloride (180.9 mg, 1.5 mmol) at 0° C. The reaction mixture was stirred overnight at room temperature which was quenched with H2O (150 mL) and extracted with EtOAc (4×50 mL). The combined organic phases were washed with brine and dried with Na2SO4. Upon filtration and evaporation of the solvent, the residue was purified by MPLC using EtOAc on silica gel to give 431.9 mg (99%) of the desired product as a colorless syrup, which was converted to a TFA salt as a white solid. 1HNMR (400 MHz, CD3OD): δ 0.22 (m, 1H), 0.45 (m, 2H), 0.57 (m, 1H), 0.86 (d, J=5.9 Hz, 6H), 1.02 (m, 1H), 1.38 (t, J=7.0 Hz, 3H), 1.83 (d, J=7.0 Hz, 3H), 2.06 (m, 2H), 2.10 (m, 1H), 3.34 (s, 3H), 4.02 (m, 3H), 4.21 (dd, J=15.0, 6.6 Hz, 1H), 4.65 (q, J=7.0 Hz, 1H), 6.90 (d, J=8.6 Hz, 2H), 7.21 (d, J=8.6 Hz, 2H), 7.28 (d, J=8.4 Hz, 1H), 7.62 (s, 1H), 7.72 (d, J=8.6 Hz, 1H). MS (ESI) (M+H)+=434.42 (M+1)+. Anal: Calcd for C27H35N3O2+0.80TFA+0.90MeOH: C, 64.00; H, 7.17; N, 7.54. Found: C, 63.98; H, 7.02; N, 7.34.
Workup
- customwas quenched with H2O (150 mL)
- extractionextracted with EtOAc (4×50 mL)
- washThe combined organic phases were washed with brine
- dry with materialdried with Na2SO4
- filtrationUpon filtration and evaporation of the solvent
- customthe residue was purified by MPLC
Sources & evidence
- ORD record
- ord-1f1919e7119841eea0d6548cfdf6af38
- Source dataset
- uspto-grants-2006_04
- Patent number
- US07030139B2
Reaction notes
Loading…